$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Moderna, BioNTech, and Novavax plunge after President Biden says the COVID-19 pandemic 'is over'
01:35pm, Monday, 19'th Sep 2022
"The pandemic is over. We still have a problem with COVID. We're still doing a low of work on it. But the pandemic is over," Biden said.
Vaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over
11:31am, Monday, 19'th Sep 2022
Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with "60 Minutes" that aired on Sunday. Moderna Inc. MRNA, -9.41% fell
Why BioNTech, Moderna And Novavax Shares Are Diving - Moderna (NASDAQ:MRNA), BioNTech (NASDAQ:BNTX)
11:03am, Monday, 19'th Sep 2022
BioNTech SE - ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) are all trading lower during Mo
Novavax says its COVID vaccine is now available in Israel for use in people aged 12 and older
08:18am, Friday, 16'th Sep 2022
Novavax Inc. NVAX, said Friday that Israel has granted an import and use permit for the company's COVID vaccine for use in people aged 12 and older. The vaccine is protein based, using a more traditio
Novavax (NVAX) Flat As Market Sinks: What You Should Know
07:13pm, Thursday, 15'th Sep 2022
Novavax (NVAX) closed the most recent trading day at $32.55, making no change from the previous trading session.
Novavax, Inc. (NVAX) Baird 2022 Global Healthcare Conference Transcript
01:55pm, Tuesday, 13'th Sep 2022
Novavax, Inc. (NASDAQ:NVAX ) Baird 2022 Global Healthcare Conference Call September 13, 2022 8:30 AM ET Company Participants Gregory Glenn - President, R&D John Trizzino - Chief Commercial Officer and
Novavax (NVAX) Gets EU Nod for COVID-19 Booster Jab in Adults
12:47pm, Tuesday, 13'th Sep 2022
Novavax (NVAX) gets authorization from the European Union to use its COVID-19 vaccine as a booster dose in adults.
Novavax, Inc. (NVAX) Presents at H.C. Wainwright 24th Annual Global Investment Conference (Transcript)
07:19pm, Monday, 12'th Sep 2022
Novavax, Inc. (NASDAQ:NVAX ) H.C. Wainwright 24th Annual Global Investment Conference September 12, 2022 4:00 PM ET Company Participants Gregory Glenn - Chief Scientific Officer John Trizzino - Chief
Novavax's COVID-19 booster is now authorized in Europe
10:25am, Monday, 12'th Sep 2022
Shares of Novavax Inc. NVAX, +1.83% were up 2.4% in trading on Monday after the company said its COVID-19 booster has been authorized in Europe for adults. Novavax's stock has declined 77.3% so far th
3 Stocks Expecting Good News From the FDA
07:37am, Monday, 12'th Sep 2022
Here are the upcoming catalysts for Mirati Therapeutics, Novavax, and Heron Therapeutics.
Nasdaq Bear Market: 3 Growth Stocks That Crashed Over 30% in August
10:45am, Thursday, 08'th Sep 2022
Are these stocks too cheap to pass up?
Should You Buy the Nasdaq's 10 Worst-Performing 2022 Stocks?
06:16am, Thursday, 08'th Sep 2022
The best performer on this list has lost three-fourths of its value this year.
Novavax (NVAX) Down 29.2% Since Last Earnings Report: Can It Rebound?
12:48pm, Wednesday, 07'th Sep 2022
Novavax (NVAX) reported earnings 30 days ago. What's next for the stock?
Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?
10:32am, Wednesday, 07'th Sep 2022
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Novavax Stock Sank to a New 52-Week Low Today
12:35pm, Tuesday, 06'th Sep 2022
The vaccine maker's recent regulatory victories aren't landing with investors.
Sign In
Buy NVAX